Selected Publications
Furie R, Hough D, Gaudy A, Ye Y, Korish S, Delev N, Weiswasser M, Zhan, Schafer P, Werth V.: Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
Lupus Science & Medicine
Lupus 9:e000581 : 2022.
Werth VP, Culton DA, Concha JSS, Graydon JS, Blumberg LJ, Okawa J, Pyzik, Blumberg RS, Hall III RS.: Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus J Invest Dermatol 141 : 2858-2865,2021.
van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A, Arnaud L, Bruce IN, Cervera R, Costedoat-Chalumeau N, Gordon C, Houssiau FA, Mosca M, Schneider M, Ward MM, Alarcon G, Aringer M, Askenase A, Bae SC, Bootsma H, Boumpas DT, Brunner H, Clarke AE, Coney C, Czirják L, Dörner T, Faria R, Fischer R, Fritsch-Stork R, Inanc M, Jacobsen S, Jayne D, Kuhn A, van Leeuw B, Limper M, Mariette X, Navarra S, Nikpour M, Olesinska MH, Pons-Estel G, Romero-Diaz J, Rubio B, Schoenfeld Y, Bonfá E, Smolen J, Teng YKO, Tincani A, Tsang-A-Sjoe M, Vasconcelos C, Voss A, Werth VP, Zakharhova E, Aranow C.: 2021 DORIS definition of remission in SLE: final recommendations from an international task force Lupus Sci Med. 8 (1): e000538,2021.
Keyes E, Jobanputra A, Feng R, Grinnell M, Vazquez T, Diaz D, Werth VP.: Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study J Am Acad Dermatol. 16:S0190-9622 (21): 02492-0,2021.
Werth VP, Askanase AD, Lundberg IE.: Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis Int J Womens Dermatol. ;7(5Part A): : 583-587,2021.
Murrell DF, Patsatsi A, Stavropoulos P, Baum S, Zeeli T, Kern JS, Roussaki-Schulze AV, Sinclair R, Bassukas I, Thomas D, Neale A, Caux F, Werth VP, Gourlay SG, Joly P, for the BELIEVE Trial Investigators: Proof-of-concept for clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase 2 BELIEVE study British J Dermatol : 2021.
Yan D, Gaffney R, Krain R, Keyes E, Concha J, Feng R, Schulz S, Pappas-Taffer L, Borucki R, Ravishankar A, Bax C, Okawa J, Werth VP.: A prospective cohort study comparing the performance of interferon gamma release assays inautoimmune skin diseases J Am Acad Dermatol. 1:S0190-9622 (21): 00651-4,2021.
Chakka S, Krain RL, Concha JSS, Chong BF, Merola JF, Werth VP.: The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review Ann Transl Med. 9 (5): 431,2021.
Fett N, Werth VP.: A multidisciplinary collaborative approach to retinal toxic effects screening for dermatology patients taking antimalarials JAMA Dermatol 157 (9): 1112-1113,2021.
Bax CE, Grinnell BA M, Concha JSS, Werth VP.: Wong-type dermatomyositis in an African American patient Arthritis & Rheumatol 73 (4): 630,2021.
Academic Contact Information
Division of Dermatology
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia,
PA
19104
Phone: 215-823-4208
Patient appointments: 800-789-7366